The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 05, 2019
Filed:
Sep. 05, 2013
Applicant:
Tracon Pharmaceuticals, Inc., San Diego, CA (US);
Inventors:
Suzanne Benedict, Carlsbad, CA (US);
Mark Cornell Manning, Johnstown, CO (US);
Brian M. Murphy, Fort Collins, CO (US);
Sharon Real, San Diego, CA (US);
Charles Theuer, San Diego, CA (US);
Assignee:
Tracon Pharmaceuticals, Inc., San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 47/22 (2006.01); C07K 16/28 (2006.01); A61K 9/00 (2006.01); A61K 47/26 (2006.01); A61K 47/12 (2006.01); C07K 16/30 (2006.01); A61K 47/18 (2017.01); A61K 9/08 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/22 (2013.01); A61K 9/0019 (2013.01); A61K 9/0048 (2013.01); A61K 47/12 (2013.01); A61K 47/26 (2013.01); C07K 16/2863 (2013.01); C07K 16/2896 (2013.01); C07K 16/30 (2013.01); A61K 9/08 (2013.01); A61K 47/183 (2013.01); A61K 2039/505 (2013.01); C07K 2317/52 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01);
Abstract
The present application relates to formulations of anti-CD105 antibodies, antigen-binding fragments thereof, and uses thereof. Another aspect relates to pre-filled syringes of the formulations of anti-CD105 antibodies or antigen-binding fragments thereof. Another aspect relates to the use of the formulations to reduce one or more signs or symptoms of an angiogenesis-related disorder such as cancers and ophthalmologic diseases.